Author: OurCrowd

[AlphaTau in GlobeNewswire] Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Investigator-Initiated Study of Alpha DaRT® in Immunocompromised Patients with Recurrent cSCC

Sep 20, 2024 |

JERUSALEM, Sept. 20, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) application to initiate a multi-center study for the treatment of recurrent cutaneous Squamous Cell Carcinoma (cSCC) in immunocompromised patients using the Alpha DaRT. Read more...

Read More

[Corelight in EIN Newswire] Vijilan Partners with Corelight to Enhance Security for MSPs, MSSPs, and Enterprises

Sep 18, 2024 |

AVENTURA, FL, UNITED STATES, September 18, 2024 /EINPresswire.com/ — Vijilan Security, a leading Managed Security Service Provider (MSSP), today announced that it is entering into a partnership with Corelight, a pioneer in Network Detection and Response (NDR) technology. The collaboration aims to enhance security services for Managed Service Providers (MSPs), MSSPs, and enterprises by addressing the critical challenge of detecting and responding to network-based threats across all assets, including networks, devices, users, applications, data, and cloud services. Read...

Read More